Development and testing of an endometrial status assessment test based on RNAampliSeq technology
- Authors: Malysheva O.V.1, Vashukova E.S.1, Gzgzyan A.M.1, Dzhemlikhanova L.K.1, Ob'edkova K.V.1, Popova A.K.1, Tkachenko A.A.1, Shalina M.A.1, Yarmolinskaya M.I.1, Glotov A.S.1
-
Affiliations:
- The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
- Issue: Vol 72, No 6 (2023)
- Pages: 77-88
- Section: Original Research
- URL: https://journals.rcsi.science/jowd/article/view/253892
- DOI: https://doi.org/10.17816/JOWD623969
- ID: 253892
Cite item
Abstract
BACKGROUND: Approximately two thirds of all implantation failures are due to impaired endometrial receptivity. The lack of implantation may be due to an implantation window failure found in approximately 25-30% of women with a history of failure to perform assisted reproductive technology protocols. The receptivity phase in such patients can be shifted in terms of timing, have a short duration, or not form. Currently, there are several commercial tests for determining endometrial receptivity based on transcriptomic data. However, these tests differ very significantly from each other in the set of genes studied, and the exact mechanism of endometrial receptivity is still not fully understood.
AIM: The aim of this study was to create and check our own test based on RNA AmpliSeq technology to assess the receptivity status of the endometrium and the implantation window.
MATERIALS AND METHODS: We previously created an RNAampliSeq panel containing 421 gens. With its use, the differential expression of these genes was analyzed in 38 endometrial samples taken in the proliferative and receptive phases.
RESULTS: The studied samples form clearly distinguishable clusters with the receptive and proliferative endometria. 271 genes from our panel are differentially expressed in different phases of the menstrual cycle.
CONCLUSIONS: We have created and tested a model that allows clearly distinguishing between the proliferative endometrium and the receptive one and identifying patients with disorders of the menstrual cycle.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Olga V. Malysheva
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: omal99@mail.ru
ORCID iD: 0000-0002-8626-5071
SPIN-code: 1740-2691
Cand. Sci. (Biol.)
Russian Federation, Saint PetersburgElena S. Vashukova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: vi_lena@list.ru
ORCID iD: 0000-0002-6996-8891
SPIN-code: 2811-8730
Cand. Sci. (Biol.)
Russian Federation, Saint PetersburgAlexander M. Gzgzyan
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: agzgzyan@gmail.com
ORCID iD: 0000-0003-3917-9493
SPIN-code: 6412-4801
MD, Dr. Sci. (Med.)
Russian Federation, Saint PetersburgLyailya Kh. Dzhemlikhanova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: dzhemlikhanova_l@mail.ru
ORCID iD: 0000-0001-6842-4430
SPIN-code: 1691-6559
MD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgKsenia V. Ob'edkova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: iagmail@ott.ru
ORCID iD: 0000-0002-2056-7907
SPIN-code: 2709-2890
MD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgAnastasiia K. Popova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: stassi1997@mail.ru
ORCID iD: 0009-0008-3512-2557
Russian Federation, Saint Petersburg
Alexander A. Tkachenko
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: castorfiber@list.ru
ORCID iD: 0000-0001-7985-0216
Russian Federation, Saint Petersburg
Maria A. Shalina
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Author for correspondence.
Email: amarus@inbox.ru
ORCID iD: 0000-0002-5921-3217
SPIN-code: 6673-2660
MD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgMaria I. Yarmolinskaya
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0002-6551-4147
SPIN-code: 3686-3605
MD, Dr. Sci. (Med.), Professor of the Russian Academy of Sciences
Russian Federation, Saint PetersburgAndrey S. Glotov
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Email: anglotov@mail.ru
ORCID iD: 0000-0002-7465-4504
SPIN-code: 1406-0090
Dr. Sci. (Biol.)
Russian Federation, Saint PetersburgReferences
- Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update. 2006;12(6):731–746. doi: 10.1093/humupd/dml004
- Haouzi D, Dechaud H, Assou S, et al. Insights into human endometrial receptivity from transcriptomic and proteomic data. Reprod Biomed Online. 2012;24(1):23–34. doi: 10.1016/j.rbmo.2011.09.009
- Lessey BA, Young SL. What exactly is endometrial receptivity? Fertil Steril. 2019;111(4):611–617. doi: 10.1016/j.fertnstert.2019.02.009
- Bai X, Zheng L, Li D, et al. Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol. 2021;19(1):122. doi: 10.1186/s12958-021-00802-4
- Enciso M, Aizpurua J, Rodríguez-Estrada B, et al. The precise determination of the window of implantation significantly improves ART outcomes. Sci Rep. 2021;11(1):13420. doi: 10.1038/s41598-021-92955-w
- Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic sDiazignature. Fertil Steril. 2011;95(1):50–60. doi: 10.1016/j.fertnstert.2010.04.063
- Ruiz-Alonso M, Blesa D, Simón C. The genomics of the human endometrium. Biochim Biophys Acta. 2012;1822(12):1931–1942. doi: 10.1016/j.bbadis.2012.05.004
- Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril. 2013;100(3):818–824. doi: 10.1016/j.fertnstert.2013.05.004
- Kibanov MV, Makhmudova GM, Gokhberg YA. In search for an ideal marker of endometrial receptivity: from histology to comprehensive molecular genetics-based approaches. Almanac of Clinical Medicine. 2019;47(1):12–25. doi: 10.18786/2072-0505-2019-47-005
- Coutifaris C, Myers ER, Guzick DS, et al.; NICHD National Cooperative Reproductive Medicine Network. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril. 2004;82(5):1264–1272. doi: 10.1016/j.fertnstert.2004.03.069
- Murray MJ, Meyer WR, Zaino RJ, et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril. 2004;81(5):1333–1343. doi: 10.1016/j.fertnstert.2003.11.030
- Ruiz-Alonso M, Valbuena D, Gomez C, et al. Endometrial Receptivity Analysis (ERA): data versus opinions. Hum Reprod Open. 2021;2021(2). doi: 10.1093/hropen/hoab011
- Altmäe S, Koel M, Võsa U, et al. Meta-signature of human endometrial receptivity: a meta-analysis and validation study of transcriptomic biomarkers. Sci Rep. 2017;7(1). doi: 10.1038/s41598-017-10098-3
- Haouzi D, Entezami F, Torre A, et al. Customized frozen embryo transfer after identification of the receptivity window with a transcriptomic approach improves the implantation and live birth rates in patients with repeated implantation failure. Reprod Sci. 2021;28(1):69–78. doi: 10.1007/s43032-020-00252-0
- Gómez E, Ruíz-Alonso M, Miravet J, et al. Human endometrial transcriptomics: implications for embryonic implantation. Cold Spring Harb Perspect Med. 2015;5(7). doi: 10.1101/cshperspect.a022996
- Predeus AV, Vashukova ES, Glotov AS, et al. Next-generation sequencing of matched ectopic and eutopic endometrium identifies novel endometriosis-related genes. Russ J Genet. 2018;54(11): 1358–1365. doi: 10.1134/S1022795418110133
- Altmäe S, Esteban FJ, Stavreus-Evers A, et al. Guidelines for the design, analysis and interpretation of ‘omics’ data: focus on human endometrium. Hum Reprod Update. 2014;20(1):12–28. doi: 10.1093/humupd/dmt048
- Horcajadas JA, Pellicer A, Simón C. Wide genomic analysis of human endometrial receptivity: new times. New opportunities. Hum Reprod Update. 2007;13(1):77–86. doi: 10.1093/humupd/dml046
- Zhang L, Liu X, Liu J, et al. The developmental transcriptome landscape of receptive endometrium during embryo implantation in dairy goats. Gene. 2017;633:82–95. doi: 10.1016/j.gene.2017.08.026
- Franasiak JM, Burns KA, Slayden O, et al. Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis. Reprod Sci. 2015;22(4):442–451. doi: 10.1177/1933719114542011
- Ohye H, Sugawara M. Dual oxidase, hydrogen peroxide and thyroid diseases. Exp Biol Med (Maywood). 2010;235(4):424–433. doi: 10.1258/ebm.2009.009241
- Pathak BR, Breed AA, Apte S, et al. Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1. Mol Cell Biochem. 2016;411(1-2):11–21. doi: 10.1007/s11010-015-2564-2
- Su MT, Huang JY, Tsai HL, et al. A common variant of PROK1 (V67I) acts as a genetic modifier in early human pregnancy through down-regulation of gene expression. Int J Mol Sci. 2016;17(2):162. doi: 10.3390/ijms17020162
- Macdonald LJ, Sales KJ, Grant V, et al. Prokineticin 1 induces Dickkopf 1 expression and regulates cell proliferation and decidualization in the human endometrium. Mol Hum Reprod. 2011;17(10):626–636. doi: 10.1093/molehr/gar031
- Chen L, Xiao D, Tang F, et al. CAPN6 in disease: an emerging therapeutic target (review). Int J Mol Med. 2020;46(5):1644–1652. doi: 10.3892/ijmm.2020.4734
- Allegra A, Marino A, Coffaro F, et al. Is there a uniform basal endometrial gene expression profile during the implantation window in women who became pregnant in a subsequent ICSI cycle? Hum Reprod. 2009;24(10):2549–2257. doi: 10.1093/humrep/dep222
- Talbi S, Hamilton AE, Vo KC, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology. 2006;147(3):1097–1121. doi: 10.1210/en.2005-1076
- Liu LJ, Liao JM, Zhu F. Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors. World J Gastrointest Oncol. 2021;13(10):1425–1439. doi: 10.4251/wjgo.v13.i10.1425
- Xu Z, Ye J, Bao P, et al. Long non-coding RNA SNHG3 promotes the progression of clear cell renal cell carcinoma via regulating BIRC5 expression. Transl Cancer Res. 2021;10(10):4502–4513. doi: 10.21037/tcr-21-1802
- Jin Z, Peng F, Zhang C, et al. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. Heliyon. 2023;9(2). doi: 10.1016/j.heliyon.2023.e13195